eMedicine Specialties > Dermatology > Benign Neoplasms

Dermatosis Papulosa Nigra

Author: Mehran Nowfar-Rad, MD,, Assistant Clinical Professor, Division of Dermatology, David Geffen School of Medicine University California at Los Angeles; Consulting Physician, Division of Dermatology, Olive View Medical Center
Coauthor(s): Frederick Fish, MD, Director, Department of Dermatology and Cutaneous Surgery, St Paul Ramsey Medical Center; Associate Clinical Professor, Department of Dermatology, University of Minnesota
Contributor Information and Disclosures

Updated: Feb 19, 2009

Introduction

Background

Dermatosis papulosa nigra (DPN) is a benign cutaneous condition common among blacks. It is usually characterized by multiple, small, hyperpigmented, asymptomatic papules on the face of adult blacks. Histologically, dermatosis papulosa nigra resembles seborrheic keratoses. The condition may be cosmetically undesirable to some patients.

Pathophysiology

The pathophysiology of dermatosis papulosa nigra is not known. The occasional positive family history may suggest a genetic propensity.

Frequency

United States

Whereas earlier studies revealed a 10% frequency in adult blacks, more recent data suggest a frequency of approximately 35% in this population.

International

Data pertaining to the international frequency of dermatosis papulosa nigra are insufficient.

Mortality/Morbidity

Dermatosis papulosa nigra is not associated with any mortality or morbidity.

Race

Dermatosis papulosa nigra affects up to 35% of the African American population.1 Blacks with a fair complexion have the lowest frequency of involvement.2 Dermatosis papulosa nigra also occurs among Asians, although the exact incidence is unknown.

Sex

Females are affected more frequently than males.2

Age

Dermatosis papulosa nigra usually begins in adolescence and is rare in persons younger than 7 years.3 The incidence of dermatosis papulosa nigra, as well as the number and size of individual lesions, increases with age.

Clinical

History

Lesions usually begin during puberty. They tend to increase steadily in number and size as the individual ages.

Physical

Dermatosis papulosa nigra is characterized by multiple, firm, smooth, dark brown to black, flattened papules that measure 1-5 mm in diameter. Lesions occur mainly on the malar area of the face and the forehead, although they also may be found on the neck, upper back, and chest. A small percentage of patients have similar lesions on the upper trunk. Scaling, crusting, and ulceration do not occur.

Causes

Dermatosis papulosa nigra is likely to be genetically determined, with 40-54% of patients having a family history of involvement. Dermatosis papulosa nigra is believed to be caused by a nevoid developmental defect of the pilosebaceous follicle. Hairston et al have suggested that dermatosis papulosa nigra should be classified within the group of epithelial nevi.4

More on Dermatosis Papulosa Nigra

Overview: Dermatosis Papulosa Nigra
Differential Diagnoses & Workup: Dermatosis Papulosa Nigra
Treatment & Medication: Dermatosis Papulosa Nigra
Follow-up: Dermatosis Papulosa Nigra
References

References

  1. Dunwell P, Rose A. Study of the skin disease spectrum occurring in an Afro-Caribbean population. Int J Dermatol. Apr 2003;42(4):287-9. [Medline].

  2. Grimes PE, Arora S, Minus HR, Kenney JA Jr. Dermatosis papulosa nigra. Cutis. Oct 1983;32(4):385-6, 392. [Medline].

  3. Babapour R, Leach J, Levy H. Dermatosis papulosa nigra in a young child. Pediatr Dermatol. Dec 1993;10(4):356-8. [Medline].

  4. Hairston MA Jr, Reed RJ, Derbes VJ. Dermatosis papulosa nigra. Arch Dermatol. May 1964;89:655-8. [Medline].

  5. Kauh YC, McDonald JW, Rapaport JA, Ruschak PJ, Luscombe HA. A surgical approach for dermatosis papulosa nigra. Int J Dermatol. Dec 1983;22(10):590-2. [Medline].

  6. Schweiger ES, Kwasniak L, Aires DJ. Treatment of dermatosis papulosa nigra with a 1064 nm Nd:YAG laser: report of two cases. J Cosmet Laser Ther. Jun 2008;10(2):120-2. [Medline].

  7. Carter EL, Coppola CA, Barsanti FA. A randomized, double-blind comparison of two topical anesthetic formulations prior to electrodesiccation of dermatosis papulosa nigra. Dermatol Surg. Jan 2006;32(1):1-6. [Medline].

  8. Andrews GC, et al. Andrews' Diseases of the Skin. 8th ed. Philadelphia, Pa: WB Saunders; 1990:752.

  9. Elder D, et al. Lever's Histopathology of the Skin. 8th ed. Philadelphia, Pa: Lippincott-Raven; 1997:693.

  10. Moschella SL, Hurley HJ. Dermatology. Philadelphia, Pa: WB Saunders; 1992:2162-3.

  11. Rook A, Wilkinson DS, Ebling FJG. Textbook of Dermatology. Vol 2. Oxford, England: Blackwell Scientific; 1998:1660-1.

Further Reading

Keywords

dermatosis papulosa nigra, DPN, hyperpigmented papules, facial papules, seborrheic keratosis

Contributor Information and Disclosures

Author

Mehran Nowfar-Rad, MD,, Assistant Clinical Professor, Division of Dermatology, David Geffen School of Medicine University California at Los Angeles; Consulting Physician, Division of Dermatology, Olive View Medical Center
Mehran Nowfar-Rad, MD, is a member of the following medical societies: American Academy of Dermatology and American Society of Dermatopathology
Disclosure: Nothing to disclose.

Coauthor(s)

Frederick Fish, MD, Director, Department of Dermatology and Cutaneous Surgery, St Paul Ramsey Medical Center; Associate Clinical Professor, Department of Dermatology, University of Minnesota
Frederick Fish, MD is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Micrographic Surgery and Cutaneous Oncology, American College of Physicians, American Medical Association, American Society for Laser Medicine and Surgery, American Society of Dermatopathology, Pacific Dermatologic Association, and Sigma Xi
Disclosure: Nothing to disclose.

Medical Editor

Kathryn Schwarzenberger, MD, Associate Professor of Medicine, Division of Dermatology, University of Vermont College of Medicine; Consulting Staff, Division of Dermatology, Fletcher Allen Health Care
Kathryn Schwarzenberger, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Contact Dermatitis Society, American Dermatological Association, Dermatology Foundation, Medical Dermatology Society, and Women's Dermatologic Society
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Edward F Chan, MD, Clinical Assistant Professor, Department of Dermatology, University of Pennsylvania School of Medicine
Edward F Chan, MD is a member of the following medical societies: American Academy of Dermatology, American Society of Dermatopathology, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

CME Editor

Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.